1. FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies. (May 2022) Authors: Antoniotti, Carlotta; Germani, Marco M.; Rossini, Daniele; Lonardi, Sara; Pietrantonio, Filippo; Santini, Daniele; Marmorino, Federica; Allegrini, Giacomo; Daniel, Francesca; Raimondi, Alessandra; Borelli, Beatrice; Zaniboni, Alberto; Conca, Veronica; Abraham, Jim; Spetzler, David; Maiello, Evari... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature. (February 2022) Authors: Lombardi, Pasquale; Rossini, Daniele; Crespi, Veronica; Germani, Marco Maria; Bergamo, Francesca; Pietrantonio, Filippo; Santini, Daniele; Allegrini, Giacomo; Daniel, Francesca; Pagani, Filippo; Antoniotti, Carlotta; Zaniboni, Alberto; Conca, Veronica; Latiano, Tiziana Pia; Boccaccino, Alessandra... Journal: Cancer treatment reviews Issue: Volume 103(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers. Issue 2 (2nd February 2022) Authors: Fucà, Giovanni; Cohen, Romain; Lonardi, Sara; Shitara, Kohei; Elez, Maria Elena; Fakih, Marwan; Chao, Joseph; Klempner, Samuel J; Emmett, Matthew; Jayachandran, Priya; Bergamo, Francesca; García, Marc Díez; Mazzoli, Giacomo; Provenzano, Leonardo; Colle, Raphael; Svrcek, Magali; Ambrosini, Margher... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications. (1st September 2021) Authors: Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietran... Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 2(2022) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial. Issue 7 (July 2022) Authors: Antoniotti, Carlotta; Rossini, Daniele; Pietrantonio, Filippo; Catteau, Aurélie; Salvatore, Lisa; Lonardi, Sara; Boquet, Isabelle; Tamberi, Stefano; Marmorino, Federica; Moretto, Roberto; Ambrosini, Margherita; Tamburini, Emiliano; Tortora, Giampaolo; Passardi, Alessandro; Bergamo, Francesca; Kas... Journal: Lancet oncology Issue: Volume 23:Issue 7(2022) Page Start: 876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies. (July 2022) Authors: Rossini, Daniele; Germani, Marco M.; Lonardi, Sara; Pietrantonio, Filippo; Dell'Aquila, Emanuela; Borelli, Beatrice; Allegrini, Giacomo; Maddalena, Giulia; Randon, Giovanni; Marmorino, Federica; Zaniboni, Alberto; Buonadonna, Angela; Boccaccino, Alessandra; Conca, Veronica; Antoniotti, Carlotta; ... Journal: European journal of cancer Issue: Volume 170(2022) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study. (August 2021) Authors: Moretto, Roberto; Giordano, Mirella; Poma, Anello M.; Passardi, Alessandro; Boccaccino, Alessandra; Pietrantonio, Filippo; Tomasello, Gianluca; Aprile, Giuseppe; Lonardi, Sara; Conca, Veronica; Granetto, Cristina; Frassoldati, Antonio; Clavarezza, Matteo; Bertolini, Alessandro S.; Germani, Marco ... Journal: European journal of cancer Issue: Volume 153(2021) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗